Janssen Announces Collaboration with Gilead to Develop PREZISTA®-based Single-tablet Regimen for the Treatment of People Living with HIV

Janssen R&D Ireland Ltd [Pressemappe]
Cork, Ireland (ots/PRNewswire) – — Two Companies to also Collaborate on the Further Development of Complera(R), Marketed as Eviplera(R) in the European Union — Janssen R&D Ireland (Janssen) announced today an amendment to its existing agreement … Lesen Sie hier weiter…